2 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Citalopram for Sx/Util in Acute Coronary Syndrome Patients Citalopram - Acute Coronary Syndrome | Phase 1 / Phase 2 | Withdrawn | Henry Ford Health System | 2016-01-01 | 2022-12-09 | |
| Gene Therapy for the Treatment of Chronic Stable Angina VM202 - Myocardial Ischemia | Phase 1 / Phase 2 | Withdrawn | Helixmith Co., Ltd. | 2015-03-01 | 2025-09-25 |
Acute Coronary Syndrome (1) · Coronary Disease (1) · Ischemia (1) · Myocardial Ischemia (1) · Patient Acceptance of Health Care (1)
Cardiovascular Diseases (2) · Chest Pain (2) · Heart Diseases (2) · Neurologic Manifestations (2) · Pain (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Vascular Diseases (2) · Behavior (1) · Health Behavior (1) · Myocardial Ischemia (1) · Pathologic Processes (1) · Treatment Adherence and Compliance (1)
Citalopram (1)
Helixmith Co., Ltd. (1) · Henry Ford Health System (1)
United States (2)